Top

Published in:

01-08-2013

Extended Lymphadenectomy in Pancreatic Cancer Is Crucial

Author: Tsutomu Fujii

Published in: World Journal of Surgery | Issue 8/2013

Abstract

Lymph node metastasis is considered one of the most significant factors associated with postoperative prognosis in patients with pancreatic cancer. Some prospective studies found no significant differences in survival between patients who underwent pancreatic cancer surgery with extended lymphadenectomy and those who underwent surgery with standard lymphadenectomy. However, recent reports, such as those describing the significance of the metastatic to examined lymph node ratio, suggest the need for some degree of lymphadenectomy. This review describes the findings of published studies and discusses the usefulness of LN dissection in patients with pancreatic cancer.

Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29PubMedCrossRef

Nakao A, Fujii T, Sugimoto H et al (2006) Oncological problems in pancreatic cancer surgery. World J Gastroenterol 12:4466–4472PubMed

Kanda M, Fujii T, Kodera Y et al (2011) Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg 98:268–274PubMedCrossRef

Oettle H, Post S, Neuhaus P et al (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 297:267–277PubMedCrossRef

Nakao A, Takeda S, Inoue S et al (2006) Indications and techniques of extended resection for pancreatic cancer. World J Surg 30:976–982. doi:10.1007/s00268-005-0438-6 PubMedCrossRef

Nakao A, Takeda S, Sakai M et al (2004) Extended radical resection versus standard resection for pancreatic cancer: the rationale for extended radical resection. Pancreas 28:289–292PubMedCrossRef

Kato K, Yamada S, Sugimoto H et al (2009) Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival. Pancreas 38:605–612PubMedCrossRef

Fujii T, Kanda M, Kodera Y et al (2012) Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: a comparative study comparing three surgical procedures. Ann Surg Oncol 19:176–183PubMedCrossRef

Mollberg N, Rahbari NN, Koch M et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254:882–893PubMedCrossRef

10.

Nakao A, Kanzaki A, Fujii T et al (2012) Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer. Ann Surg 255:103–108PubMedCrossRef

11.

Müller SA, Hartel M, Mehrabi A et al (2009) Vascular resection in pancreatic cancer surgery: survival determinants. J Gastrointest Surg 13:784–792PubMedCrossRef

12.

Artinyan A, Soriano PA, Prendergast C et al (2008) The anatomic location of pancreatic cancer is a prognostic factor for survival. HPB (Oxford) 10:371–376CrossRef

13.

Howard TJ, Krug JE, Yu J et al (2006) A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon’s contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10:1338–1345PubMedCrossRef

14.

Ueda M, Endo I, Nakashima M et al (2009) Prognostic factors after resection of pancreatic cancer. World J Surg 33:104–110. doi:10.1007/s00268-008-9807-2 PubMedCrossRef

15.

Delcore R, Rodriguez FJ, Forster J et al (1996) Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg 172:463–468PubMedCrossRef

16.

Fujita T, Nakagohri T, Gotohda N et al (2010) Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas. Pancreas 39:e48–e54PubMedCrossRef

17.

Murakami Y, Uemura K, Sudo T et al (2010) Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma. World J Surg 34:1900–1907. doi:10.1007/s00268-010-0577-2 PubMedCrossRef

18.

Kanda M, Fujii T, Nagai S et al (2011) Pattern of lymph node metastasis spread in pancreatic cancer. Pancreas 40:951–955PubMedCrossRef

19.

Evans DB, Farnell MB, Lillemoe KD et al (2009) Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement. Ann Surg Oncol 16:1736–1744PubMedCrossRef

20.

Ibukuro K (2001) Vascular anatomy of the pancreas and clinical applications. Int J Gastrointest Cancer 30:87–104PubMedCrossRef

21.

Kayahara M, Nagakawa T, Kobayashi H et al (1992) Lymphatic flow in carcinoma of the head of the pancreas. Cancer 70:2061–2066PubMedCrossRef

22.

Fernández-Cruz L, Johnson C, Dervenis C (1999) Locoregional dissemination and extended lymphadenectomy in pancreatic cancer. Dig Surg 16:313–319PubMedCrossRef

23.

Sahin TT, Fujii T, Kanda M et al (2011) Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas. Pancreas 40:1029–1033PubMedCrossRef

24.

Yamada S, Nakao A, Fujii T et al (2009) Pancreatic cancer with para-aortic lymph node metastasis: a contraindication for radical surgery? Pancreas 38:e13–e17PubMedCrossRef

25.

Fortner JG (1973) Regional resection and pancreatic carcinoma. Surgery 73:799–800PubMed

26.

Nakao A, Kaneko T, Takeda S et al (2001) The role of extended radical operation for pancreatic cancer. Hepatogastroenterology 48:949–952PubMed

27.

Henne-Bruns D, Vogel I, Lüttges J et al (2000) Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 24:595–601. doi:10.1007/s002689910089 PubMedCrossRef

28.

Capussotti L, Massucco P, Ribero D et al (2003) Extended lymphadenectomy and vein resection for pancreatic head cancer: outcomes and implications for therapy. Arch Surg 138:1316–1322PubMedCrossRef

29.

Pedrazzoli S, DiCarlo V, Dionigi R et al (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy study group. Ann Surg 228:508–517PubMedCrossRef

30.

Yeo CJ, Cameron JL, Lillemoe KD et al (2002) Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg 236:355–366PubMedCrossRef

31.

Farnell MB, Pearson RK, Sarr MG et al (2005) A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 138:618–628PubMedCrossRef

32.

Nimura Y, Nagino M, Takao S et al (2012) Standard versus extended lymphadenectomy in radical pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas: long-term results of a Japanese multicenter randomized controlled trial. J Hepatobiliary Pancreat Sci 19:230–241PubMedCrossRef

33.

Peparini N, Chirletti P (2012) Extended lymphadenectomy does not improve prognosis in pancreatic carcinoma: is that really so? J Hepatobiliary Pancreat Sci 19:297–298PubMedCrossRef

34.

Slidell MB, Chang DC, Cameron JL et al (2008) Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol 15:165–174PubMedCrossRef

35.

Peschaud F, Benoist S, Julié C et al (2008) The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 248:1067–1073PubMedCrossRef

36.

Kulig J, Sierzega M, Kolodziejczyk P et al (2009) Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer. Br J Surg 96:910–918PubMedCrossRef

37.

Riediger H, Keck T, Wellner U et al (2009) The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 13:1337–1344PubMedCrossRef

38.

Valsangkar NP, Bush DM, Michaelson JS et al (2013) N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. J Gastrointest Surg 17:257–266PubMedCrossRef

39.

Title: Extended Lymphadenectomy in Pancreatic Cancer Is Crucial
Author: Tsutomu Fujii
Publication date: 01-08-2013
Publisher: Springer US
Published in: World Journal of Surgery / Issue 8/2013
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI: https://doi.org/10.1007/s00268-013-2039-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Extended Lymphadenectomy in Pancreatic Cancer Is Crucial

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2013

Systematic Review and Meta-analysis of Enhanced Recovery After Pancreatic Surgery with Particular Emphasis on Pancreaticoduodenectomies

Extended Lymphadenectomy in Colon Cancer Is Debatable

Extended Lymphadenectomy in Gastric Cancer Is Crucial

Low Perioperative Prealbumin Level Predicts Early Recurrence After Curative Pulmonary Resection for Non-small Cell Lung Cancer

Outcome Prediction of Pulmonary Metastasectomy Can Be Evaluated Using Metastatic Lesion in Osteosarcoma Patients

Nationally Representative Household Survey of Surgery and Mortality in Sierra Leone